drugset / Trial / NCT04942665
Low Dose ICG for Biliary Tract and Tumor Imaging
RandomizedParallel-groupDouble-blindDiagnostic
Summary
Near-infrared fluorescence (NIRF) imaging after an intravenous injection of indocyanine green (ICG) allows for the intraoperative identification of liver anatomy. The investigators have new data that a much lower dose improves this visualization. Confirmation of this hypothesis would mean that ICG can be administered on the same day of surgery in order to augment real-time intraoperative visualization, thereby providing a safe, feasible, and cost-effective strategy for the surgical treatment of liver disease.
Timeline
- Start
- 2021-09-15
- Primary completion
- 2022-09-15
- Completion
- 2023-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 0.05 mg | Intravenous |
| Subject | Indocyanine Green | Diagnostic / imaging agent | 2.5 mg | Intravenous |